Baird Medical Investment Holdings Warrant
BDMDW
29 hedge funds and large institutions have $439K invested in Baird Medical Investment Holdings Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
2.76% less ownership
Funds ownership: 54.26% → 51.5% (-2.8%)
9% less funds holding
Funds holding: 32 → 29 (-3)
14% less capital invested
Capital invested by funds: $513K → $439K (-$73.1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$14K |
| 2 |
CF
Cantor Fitzgerald
New York
|
-$8.01K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.42K |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$921 |
BDMDW Hedge Fund Activity: Q3 2025 in Review
29 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Baird Medical Investment Holdings Warrant (BDMDW) for Q3 2025, worth a combined $439K — down 14% from $513K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BDMDW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Shaolin Capital Management, exiting entirely with an estimated $14K sold.
- 29 institutional investors held Baird Medical Investment Holdings Warrant (BDMDW) as of Q3 2025, down from 32 in Q2 2025.
- Funds reported $439K of Baird Medical Investment Holdings Warrant stock for Q3 2025, down 14% quarter-over-quarter.
- 0 funds opened new Baird Medical Investment Holdings Warrant positions in Q3 2025 and 3 closed out, a net change of -3 holders.
- The largest Baird Medical Investment Holdings Warrant seller in Q3 2025 was Shaolin Capital Management, an estimated $14K sold.
Based on aggregated 13F filings for Q3 2025.